Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.50 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.48 |
| ▸ | SMPD2 | O60906 | 2/20 | 0.48 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.48 |
| ▸ | CERT1 | Q9Y5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6569117 | 0.90 | ALDH1A1 (0.51) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6569341 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6568705 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6569302 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6570354 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL7618294 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6570288 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6569383 | 0.88 | LPAR3 (0.58) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL6568701 | 0.86 | LPAR3 (0.56) | ALDH1A1ASAH1ACER2LPAR1LPAR3 | |
| SCHEMBL7618284 | 0.86 | ASAH1 (0.56) | ALDH1A1ASAH1ACER2LPAR1SMPD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1156054-B1 | DRUGS CONTAINING PHOSPHORIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2004-04-14 | — | — | EP | claimed |
| US-6495533-B1 | TUMOR NECROSIS FACTOR INHIBITORS; RHEUMATOID ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE, HEPATITIS, SEPSIS, HEMORRHAGIC SHOCK, MULTIPLE SCLEROSIS, CEREBRAL INFARCTION, DIABETES, INTERSTITIAL PNEUMONIA, PAIN, HIV | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | claimed |
| EP-1156054-A1 | DRUGS CONTAINING PHOSPHORIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-11-21 | — | — | EP | claimed |
| EP-1156054-B1 | DRUGS CONTAINING PHOSPHORIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-6495533-B1 | TUMOR NECROSIS FACTOR INHIBITORS; RHEUMATOID ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE, HEPATITIS, SEPSIS, HEMORRHAGIC SHOCK, MULTIPLE SCLEROSIS, CEREBRAL INFARCTION, DIABETES, INTERSTITIAL PNEUMONIA, PAIN, HIV | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-1156054-A1 | DRUGS CONTAINING PHOSPHORIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-11-21 | — | — | EP | disclosed |